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Techniques to Reduce the 
Magnitude and Duration of 
Redistribution Hypothermia in 
Adults
Jonathan V. Roth
Abstract
While much effort has been devoted to correcting intraoperative hypothermia 
and documenting the adverse outcomes associated with hypothermia, less atten-
tion has been directed to preventing redistribution hypothermia in the first place. 
Methods currently exist that can reduce the magnitude of redistribution hypo-
thermia, but are not widely practiced. This chapter focuses on the pathophysiol-
ogy of redistribution hypothermia and the currently available methods that can 
be employed to reduce redistribution hypothermia. Additional promising, but 
currently unproven, methods are discussed. Since hypothermia causes adverse 
outcomes, it is anticipated that the reduction in redistribution hypothermia will 
improve patient outcome.
Keywords: redistribution hypothermia, hypothermia, perioperative hypothermia, 
intraoperative hypothermia, inhalation induction, anesthesia induction
1. Background
Hypothermia has multiple adverse consequences and should be avoided (Table 1) 
[1, 2]. The Anesthesia Patient Safety Foundation has recently reaffirmed that even mild 
hypothermia is associated with an increase in complications [3]. In studies assessing 
whether patients were hypothermic, typically the end-of-case temperature has been 
used for this determination and its association with complications. With the exception 
of one study where there was increased blood loss at 36.5°C [4], an increase in complica-
tions occurs when the end-of-case temperature is <36.0°C. However, there is increasing 
recognition that intraoperative temperature matters. The American College of Surgeons 
consider intraoperative hypothermia to be a modifiable risk factor for surgical site 
infections; they recommend the maintenance of intraoperative normothermia and the 
use of prewarming [5]. The 2017 Centers for Disease Control and Prevention (CDC) 
guidelines recommend maintenance of perioperative normothermia [6].
While much effort has been devoted to documenting adverse outcomes 
and correcting intraoperative hypothermia, relatively little attention has been 
directed to preventing intraoperative hypothermia in the first place. “Despite 
Active Warming, Hypothermia Is Routine in the First Hour of Anesthesia” 
was written on the cover of the February 2015 issue of Anesthesiology. In a 
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retrospective review, Sun et al. found 64% of 58,814 adult patients had a tem-
perature measurement under 36.0°C after 45 min [7]. Some hypothermia com-
plications occur intraoperatively (e.g., coagulopathy and increased transfusion 
requirements), some postoperatively (e.g., shivering and delayed emergence) 
and some likely both (e.g., infection risk). The contribution of intraoperative 
hypothermia to postoperative complications may often be unrecognized. For 
example, patients may have decreased immunologic defense against infection at 
the time of incision, that is, during the vulnerable period when infections can 
become established. It is plausible that, if redistribution hypothermia can be 
reduced, one may be able to reduce the intraoperative and postoperative compli-
cations associated with hypothermia, particularly in situations where patients 
are at increased risk of developing a greater degree of hypothermia or may have 
increased risk of hypothermia-associated complications (Table 2). End-of-case 
hypothermia implies intraoperative hypothermia. End-of-case normothermia 
does not imply intraoperative normothermia. A patient may have been hypo-
thermic intraoperatively, having suffered the consequences of intraoperative 
hypothermia, achieving normothermia only at the end of the case.
The body contains three thermal zones: the core (abdomen, thorax, and brain), 
the periphery (the extremities), and the skin. At rest, the core temperature is 37.0°C 
(36.5–37.5°C) and the periphery is 2–4°C cooler. The skin temperature can approach 
ambient temperature. At rest, most of the basal heat production occurs in the core. 
Heat travels from the core to the periphery to the skin and out to the environment. 
In the steady state, the rate of heat loss equals the rate of heat production, and the 
heat content of the body remains the same. Since temperature is just a measurement 
that reflects heat content, the temperature remains the same. The body normally 
maintains core temperature within a narrow range. Within limits, the periphery 
can act as a temperature buffer as it can add or lose heat, changing its temperature, 
while keeping the core temperature within a narrow range. The core temperature is 
the temperature that is physiologically most important [8].
There are behavioral (e.g., seeking an environment of a different temperature 
and changing clothing) and physiologic defenses to thermal challenges. Under 
anesthesia only the physiologic defenses are available. As one becomes too warm, 
the first physiologic defense is to vasodilate. If the temperature increases further, 
• Morbid cardiac events (ischemia, infarctions, arrhythmias, sympathetic activation)
• Surgical wound infection
• Coagulopathy, increased blood loss, increased transfusion requirements
• Patient discomfort, postoperative shivering
• More likely to require postoperative ventilation
• Adverse respiratory events in PACU
• Delayed wake-up
• Prolonged PACU stays
• Increased hospital length of stay
• Negative nitrogen balance
• Delayed wound healing
• Increased financial cost of care of hypothermia complications
• Failure to meet MACRA standard
Table 1.  
Complications of hypothermia.
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the patient perspires. As one cools, the first defense is to vasoconstrict. If the 
temperature decreases further, the patient shivers [9]. These physiologic defenses 
are impaired during anesthesia.
There is a large vascular supply to the periphery and skin, but at rest these ves-
sels are relatively vasoconstricted and there is relatively little blood flow. The blood 
flow to the periphery and skin can increase if these blood vessels vasodilate because 
of the administration of a vasodilator (or there is an increased metabolic need such 
as what occurs during physical activity). If pharmacologic-induced vasodilation 
occurs, the increased blood flow to the periphery transfers more heat from the 
core to the periphery and skin. As a result, the core’s temperature decreases while 
that of the periphery will increase. This process is called redistribution hypo-
thermia. Since heat only travels from higher to lower temperature (second law of 
Risk posed by postoperative hyperdynamic/tachycardic response to hypothermia
Coronary artery disease
Stenotic valvular heart disease
Dynamic obstructive cardiomyopathies
Increased risk or consequence of infection
Immunocompromised
Colon surgery
Foreign body placement (e.g., artificial joints)
Potential for large blood loss increased by hypothermia- induced coagulopathy
Spine surgery
Liver surgery
Prostate resection
Large exposure of tissues that have a propensity to bleed
Hypercarbia exacerbating hypothermia-induced coagulopathy
Increased risk of hypothermia due to patient characteristics
Elderly
Frail
Inability or delay in warming patient or environment
Lateral or prone positioning
Other prolonged positioning
Robotic surgery
Axillary-bifemoral artery bypass
Large surface area burn
Remote location with inability to adjust ambient temperature
Warming devices not available
Risk from hypothermia- induced vasoconstriction
Vascular surgery
Raynaud’s disease or syndrome
Free flap with arterial vascular anastomosis
Table 2. 
Examples of situations where patients are at increased risk of developing a greater degree of hypothermia or 
may have increased risk of hypothermia-associated complications.
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thermodynamics), the heat in the periphery cannot be transferred back to the core. 
However, warming the periphery decreases the temperature gradient between the 
core and periphery. A smaller temperature gradient reduces the rate of heat transfer 
from the core [10]. Thus, more of the heat produced in the core will remain in the 
core, thus contributing to increasing the core temperature or decreasing the rate of 
core temperature decrease. If the periphery is warmed to a temperature greater than 
the core, heat can be transferred from the periphery to the core.
Propofol administration causes vasodilation and thus redistribution hypo-
thermia. Propofol inductions typically result in a decrease in core temperature of 
about 1.5°C [11–13]. While there is also heat loss to the environment (via con-
duction, convection, radiation, evaporation, and airway losses), redistribution 
hypothermia is the major reason for the core temperature decrease in the first 
15–60 min of an anesthetic. Although not specified in Sun’s results, because pro-
pofol is the most common method of anesthetic induction in developed nations, 
it is likely most of these patients were induced with intravenous propofol and can 
explain the 64% incidence hypothermia (core temperature < 36.0°C) found in 
his review [7].
With this understanding, the following physiologic strategies have been studied 
to reduce redistribution hypothermia: (1) reduce the increased blood flow to the 
periphery and skin, (2) prewarm the periphery and skin, (3) increase metabolic 
activity, and (4) warm the environment. This chapter will discuss actual and 
potential methods available to reduce the magnitude and duration of redistribution 
hypothermia in adults.
2. Studied methods to reduce redistribution hypothermia
2.1 Reducing the increased blood flow to the periphery and skin
2.1.1 Etomidate
Compared to propofol, etomidate inductions result in a lesser initial temperature 
drop (1.4 vs. 0.5°C) [12]. Because of the adrenal axis suppression resulting from 
etomidate [14], the author does not recommend using etomidate just for thermal 
stability. However, if etomidate is used for other indications, one would expect a 
thermal benefit.
2.1.2 Ketamine
Compared to propofol, ketamine inductions result in a lesser initial temperature 
drop (1.5 vs. 0.9°C) [13]. Because of the risk of emergence reactions and hallucina-
tions from an anesthetic dose of ketamine [15], the author does not recommend 
using ketamine just for thermal stability. However, if an anesthetic dose of ket-
amine is used for other indications, one would expect a thermal benefit.
2.1.3 Phenylephrine infusion
Ikeda et al. have demonstrated that a phenylephrine infusion of 0.5 mcg/kg/
min starting immediately before induction with 2.5 mg/kg propofol results in an 
initial lower temperature decrease compared to propofol after the first hour (1.2 vs. 
0.5°C decrease after 1 h) [16]. Presumably the vasoconstriction from phenylephrine 
opposes the vasodilation resulting from propofol administration. In addition, the 
patients who received the phenylephrine infusion maintained a higher mean arterial 
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blood pressure (83 ± 9 vs. 72 ± 8 mm Hg, mean ± SD). (It seems plausible that any 
technique discussed in this section that reduces vasodilation has the potential to 
accrue an additional benefit of reducing induction-associated hypotension. This 
hypothesis requires investigation.)
2.1.4 Phenylephrine bolus
A 160 mcg bolus of phenylephrine immediately prior to 2.2 mg/kg propofol 
reduces the mean decrease in core temperature by about 0.43°C in the first hour than 
those who did not receive the phenylephrine bolus [17, 18]. While redistribution 
hypothermia can continue for up to 3 h, a large part of the temperature decrease 
occurs within the first 15 min. The vasoconstricting effect of a bolus of phenyleph-
rine lasts sufficiently long to oppose much of the maximal vasodilation resulting 
from propofol induction. While most patients decrease their blood pressure after 
propofol administration, the bolus phenylephrine reduced the incidence of propofol-
induced hypotension from 98 to 58% [17, 18]. While generally effective, the 160 mcg 
dose was used on all patients in this study but may not be optimal. Some patients 
still became hypotensive (systolic BP < 85 mm Hg), and 1 patient in this group of 
50 patients increased the systolic blood pressure to >180 mm Hg [17, 18]. It remains 
to be determined if a weight-based dose could be found that further reduces the 
incidence of hypotension, avoids dangerous hypertension, and still maintains the 
thermal benefit.
2.1.5 Inhalation inductions
Ikeda et al. demonstrated less core hypothermia when anesthesia is induced 
with inhaled sevoflurane than with intravenous propofol (1.5 vs. 0.8 °C decrease 
after 1 h) [11]. This study of 10 patients in each group was done at a time when the 
concept of redistribution hypothermia was still in development and the harmful 
effects of even mild hypothermia were not as well appreciated as they are today. A 
recent study (50 patients in each of six groups) replicated and strengthened these 
findings [17, 18]. Inhalation inductions of 8% sevoflurane in either 100% oxygen 
or 50% oxygen/50% nitrous oxide resulted in a higher mean temperature by about 
0.5°C than those who received 2.2 mg/kg propofol in patients aged 18–55 years 
[17, 18]. Inhalation inductions were also found effective in reducing redistribution 
hypothermia in older (56–88 years, mean 67.2 years) patients. Elderly patients 
have an increased risk for hypothermia [19–21] for reasons that include decreased 
metabolic activity, decreased muscle mass, an impaired vasoconstriction response, 
and an impaired shivering response. A previous study also concluded that inhala-
tion induction is more hemodynamically stable than IV propofol inductions [22]. 
In contrast to propofol inductions where significant hypotension can occur imme-
diately, an inhalation induction typically causes a more gradual decrease in blood 
pressure which can be treated before severe hypotension develops.
In adults, anesthetic inductions are achieved most commonly by intravenous, 
not inhalation, inductions for reasons that include inhalation inductions take extra 
time, room contamination with anesthetic gases, and possible patient dissatisfac-
tion. An inhalation induction takes 1–2 min longer than an intravenous induction 
[17, 18] and that lost time may be recovered by a quicker wake-up because of the 
patient being warmer. However, Muzi et al. demonstrated that the speed of inhala-
tion induction approached that of an intravenous induction using a primed circuit 
[23]. Although many anesthesia practitioners may assume patients would not want 
the inhalation technique, when offered a choice, 50% chose an inhalation induction, 
33% chose IV induction, and 17% were undecided [24].
Autonomic Nervous System Monitoring - Heart Rate Variability
6
Inhalation inductions are not for everyone. Medical contraindications would 
include concern of increased intracranial pressure, indication for hypothermia, 
contraindication to hyperthermia (e.g., multiple sclerosis), increased aspiration 
risk, unfavorable airway anatomy, and patient fear of face masks. Since patients 
may lighten more rapidly when the face mask is removed for endotracheal intuba-
tion than with propofol, it may be prudent to avoid inhalation inductions when 
intubation may be a more prolonged process as there may potentially be an 
increased risk of awareness than a propofol induction. Examples would include 
inserting double-lumen tubes or training novice laryngoscopists.
However, there are additional potential benefits to preforming inhalation induc-
tions. First, there will be no pain on propofol injection. Second, trainees will get more 
practice with airway management. In current practice, most patients after IV induc-
tion immediately receive a laryngeal mask airway (LMA) or endotracheal intubation. 
Third, future propofol shortages can be mitigated by employing inhalation inductions. 
Fourth, LMAs may be easier to insert while patients are breathing spontaneously as the 
airway tends to open during inspiration and there is less of an obstruction to proper 
LMA positioning than a totally collapsed airway one typically gets after IV propofol 
inductions. Fifth, there will be less second-hand exposure to propofol, currently a 
candidate factor in propofol addiction. Sixth, inhalation inductions may be a superior 
alternative over other induction agents to patients with allergies to propofol. Seventh, 
with intravenous inductions, atelectasis develops very quickly. One would expect that 
with spontaneous ventilation, there may be less atelectasis, but this will need to be 
studied. In patients breathing spontaneously via an LMA after IV propofol induction, 
one does not have to manage a patient who becomes apneic, thus eliminating extra 
tasks and saving time while starting a case. Lastly, propofol supports bacterial growth 
[25]. There is an increased number of colony-forming units in the stopcocks of patients 
who received propofol (10× at 24 h and >100× at 48 h) compared to those who did not 
[26]. While it is not established that this is a cause of increased infections, the avoid-
ance of propofol would eliminate this as a concern. Removing the stopcocks could also 
address this concern but that adds cost and likely would not be universally done.
2.1.6 Nitrous oxide
Previous work suggests an ongoing thermal benefit to using nitrous oxide. 
Ozaki et al. found nitrous oxide impairs thermoregulation less than sevoflurane or 
isoflurane [27]. The threshold for vasoconstriction was 35.8 ± 0.3°C (mean ± SD) in 
the patients given 50% nitrous oxide combined with 0.5 MAC sevoflurane, which 
was statistically significantly greater than that in those given 1.0 MAC sevoflurane: 
35.1 ± 0.4°C. Similarly, the threshold for vasoconstriction was 35.9 ± 0.3°C in the 
patients given 60% nitrous oxide combined with 0.5 MAC isoflurane, which was 
statistically significantly greater than that in those given 1.0 MAC isoflurane: 
35.0 ± 0.5°C. The use of nitrous oxide allows for the thermal defense of vasocon-
striction to activate before the patient becomes more hypothermic.
Nitrous oxide has been under challenge for several decades. Two of the rea-
sons why nitrous oxide has been out of favor with many practitioners have been 
the concern of major cardiovascular morbidity and mortality and an increased 
risk of surgical site infections (SSI). In combination with another retrospective 
study of 49,016 patients where nitrous oxide use was associated with decreased 
30-day mortality and decreased in-hospital mortality/morbidity, the results of the 
ENIGMA II have essentially eliminated these concerns [28–31]. ENIGMA II con-
cludes “Our findings support the safety profile of nitrous oxide use in major non-
cardiac surgery. Nitrous oxide did not increase the risk of death and cardiovascular 
complications or surgical site infection, the emetogenic effect of nitrous oxide can 
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be controlled with antiemetic prophylaxis, and a desired effect of reduced volatile 
agent use was shown.” [4] The other major reason for not using nitrous oxide has 
been the concern for postoperative nausea and vomiting (PONV). If a patient has 
been administered an antiemetic, there is a small nonsignificant increased risk of 
severe PONV. ENIGMA II concludes “Nitrous oxide increases the risk of severe 
PONV by only a small percentage, and the increased risk is essentially eliminated by 
antiemetic drug prophylaxis. Concern about severe PONV thus does not appear to 
be a valid reason to avoid nitrous oxide.”
Except for potential environmental concerns, there is little reason not to use 
nitrous oxide in cases that are not of long duration (>4–6 h) unless there are physi-
cal contraindications (e.g., gas space expansion). Besides from its potential thermal 
benefit, nitrous oxide has been shown to reduce chronic pain in specific populations 
(Asians and other patients with variants in the methylenetetrahydrofolate reductase 
gene) [32]. The United States is in the midst of an opioid epidemic. The major-
ity of heroin users got their start from medically prescribed opioids [33]. Nitrous 
oxide also has analgesic efficacy and may reduce intraoperative opioid use. Further 
research is needed, but the possibility of reducing chronic pain and intraoperative 
opioid use may have benefit in combatting the opioid epidemic [34].
2.2 Prewarm the periphery and skin
Prewarming is the active warming of the body surface, often via forced-air 
warming, prior to induction of general or central neuraxial anesthesia. It is currently 
the most effective method of reducing redistribution hypothermia. It has been 
extensively studied, and, in addition to demonstrating warmer core temperatures, 
improved outcomes (decreased blood loss, transfusion requirement, and infection 
rate) have been demonstrated. (A recent chapter reviews much of the relevant detail 
and will not be repeated here [10]. A small representative sample of studies are listed 
[35–39].) Prewarming is fundamentally different from all other techniques in that it’s 
the only technique that exogenously adds heat content to the patient. However, the 
technique is not universally used [40]. Obstacles to its use include (1) requirement of 
space, equipment, supplies, and personnel time, (2) change in the pattern of patient 
flow, (3) patient refusal or intolerance, (4) requirement of cleaning if reusable 
equipment is utilized, (5) insufficient availability of a power supply, (6) requirement 
to train personnel, (7) bypass of the holding area, (8) additional equipment mainte-
nance requirement, and (9) inadequate knowledge of the value of prewarming [10].
Prewarming works by adding heat content to the periphery. This decreases 
the temperature gradient between core and periphery and thus decreases the 
heat transfer and redistribution hypothermia. Any method that can increase the 
peripheral temperature will reduce redistribution hypothermia. Any event that 
decreases peripheral temperature will increase redistribution. Thus, all reasonable 
efforts should be made to keep the periphery warm before induction of anesthesia. 
After application of forced-air warming, it will take time (usually 30 min) until an 
increase in core temperature occurs [41, 42]. This delay occurs because the periph-
ery needs to be warmed before there is a significant effect on core temperature.
The efficacy of prewarming can be limited by sweating, thermal discomfort, 
and efficacy of the warming device. Sessler et al. found that 30 min of prewarming 
increased peripheral tissue heat content by more than the amount normally dis-
tributed during the first hour of anesthesia [43]. Since there are other and ongoing 
mechanisms of heat loss, prewarming more than 30 min will likely benefit many 
patients. However, if it is difficult to arrange for 30+ min of prewarming or the 
patient does not tolerate the longer durations, even 10–20 min of prewarming is 
effective in reducing hypothermia and shivering [44].
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Because of redistribution hypothermia, ideally, every patient undergoing general 
or neuraxial anesthesia should be prewarmed [45, 46]. If the patient receives just a 
peripheral nerve block, there is little risk of hypothermia. Prewarming (and forced-air 
warming) should not be applied over ischemic limbs. Normally when there is heat 
transfer to an area of the body, blood circulation removes the heat from that area, thus 
decreasing the local temperature. If there is impaired blood flow, it is possible that 
the heat accumulation from prewarming or intraoperative forced-air warming could 
cause tissue damage. (In therapeutic hyperthermia, temperatures >42.0°C have been 
associated with tissue damage such as fat necrosis [47].) For similar reasons, forced-air 
warming over the lower extremities should be turned off during aortic cross-clamping. 
Also, in theory, there may be more risk of cell death from warming ischemic tissue 
because of the resulting increase in metabolic oxygen demand in combination with the 
impaired blood supply. It may be prudent to avoid prewarming when there is a contra-
indication to hyperthermia (e.g., risk of neurologic ischemia and pregnancy).
There is no data to guide the decision to use prewarming on patients who are 
hyperthermic preoperatively. Patients are hyperthermic because either (1) their 
cooling mechanisms have been overwhelmed as that which occurs in heat exhaus-
tion or heatstroke (nonfebrile hyperthermia) or (2) they have an elevated tempera-
ture set point as occurs with many infections (febrile hyperthermia). The nonfebrile 
patients probably should be allowed to have their core temperature normalized 
and thus probably should not be prewarmed. It has been suggested that the febrile 
patients should be allowed to remain hyperthermic intraoperatively [48]. There is 
overwhelming evidence that fever is part of a coordinated defense system [49, 50]. 
The lines of evidence include evolutionary, correlative, antipyretic, and hyperther-
mia/hypothermia studies [49]. For example, infectious illnesses in animals are of 
longer duration, and mortality rates increase if the fever is treated [49]. Some of 
the enzymes in the immune system have a temperature optima in the febrile range. 
In addition, if the temperature of these patients decrease to below their elevated 
temperature set point and the set point does not change during the anesthetic, then 
these patients will behave postoperatively as though they are hypothermic (e.g., 
increasing metabolism and cardiac output, shivering), even if their temperature is 
>37.0°C. Thus, although unproven, there is reason to maintain the febrile hyper-
thermia intraoperatively. It is an unanswered question as to whether these patients 
should be prewarmed.
2.3 Increase metabolic activity
2.3.1 Amino acid administration
The preoperative administration of amino acids increases metabolic heat 
production and leads to the release of insulin and leptin resulting in a mean tem-
perature increase of 0.46°C [51]. These hormones may also affect central thermo-
regulation. If amino acid infusion is started after hypothermia develops, rewarming 
is not augmented [52]. It is possible that the amino acid-induced increase in 
cardiopulmonary demands may be problematic in frail patients and those with 
reduced cardiopulmonary reserve. Since there is limited evidence, this technique is 
considered experimental.
2.3.2 Fructose administration
The preoperative administration of fructose increases metabolic heat production 
and affects central thermoregulation [53]. However, in patients with hereditary 
fructose intolerance (HFI), the infusion of fructose can lead to liver damage, kidney 
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damage, convulsions, and death. HFI often goes undiagnosed. The prevalence of 
HFI is estimated at 1 in 20,000, similar to the incidence of malignant hyperthermia 
events.
2.4 Warming the environment
As discussed above, anything that is practical and can be done to keep the 
patient warmer will likely result in the periphery remaining warmer and thus less 
redistribution. There is often a difference of opinion among various operating 
room personnel as to what temperature of the operating room should be. A cooler 
environment will increase the rate of heat loss from the patient. With the resultant 
decrease in peripheral heat content, the magnitude of redistribution hypothermia 
will be greater [8].
There are five methods of heat loss (conduction, convection, radiation, evapora-
tion, and loss via the airway). Radiation and convection losses are most important 
[54]. One of the major determinants of radiative heat loss is the temperature 
difference between the radiator (i.e., the patient) and the environment. A greater 
temperature difference will result in a greater heat loss. Another major determinant 
is the absorption/reflection properties of the environment. The author is unaware 
of any clinical data regarding these factors.
Convection refers to heat transfer resulting from the bulk movement of a fluid 
(i.e., gas or liquid). A patient will transfer heat to warm the air immediately around 
him or herself. Convective airflow will move this warm air away from the patient 
and replace it with cooler ambient air. Thus, heat loss will continue to warm the 
newly adjacent cool air. The cooler the adjacent air, the greater the rate of heat loss 
from the patient.
Surgeons generally prefer a cooler room because they are working, are under 
lights that may emit heat, may be under stress, are gowned, may be in physical con-
tact with other personnel, and may also be wearing lead aprons. An uncomfortable 
surgeon may not work at his/her best and may drip perspiration into the surgical 
wound. With modern operating rooms where the air is replaced many times an 
hour, the temperature can be adjusted within minutes. Thus, a reasonable compro-
mise would be to keep the operating room warm until the patient is prepped and 
draped and then cool the room for the benefit of the surgical team. Once the patient 
is draped, convective losses are reduced except from the surgical wound.
3. Candidate methods to reduce redistribution hypothermia
Unfortunately, none of the abovementioned techniques fully solves the redistri-
bution hypothermia problem. It is plausible that either reducing propofol dosages 
or combining techniques may provide additional thermal benefit. The following 
techniques show promise but require formal investigation:
1. Ketamine in analgesic doses is commonly used as part of a multimodal analge-
sia strategy. It is plausible that reducing the propofol dose by an analgesic dose 
of ketamine would reduce the magnitude of redistribution hypothermia. The 
induction dose of propofol (2.2 mg/kg) is similar in mg to the induction dose 
of ketamine (2 mg/kg). Reducing the propofol dose by 30 mg and replacing it 
with 30 mg ketamine seems reasonable.
2. Kazama et al. found that patients can be induced with a reduced total dose of 
propofol and with less hypotension when diluted propofol was administered 
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as an infusion [55]. It is plausible that, by using less propofol, there would be a 
lesser amount of redistribution hypothermia (and less hypotension).
3. A blended propofol-inhalation induction would utilize less propofol and thus 
potentially reduce redistribution hypothermia.
4. Combining prewarming with any of the other techniques (e.g., prewarming 
and inhalation induction, prewarming and phenylephrine prior to propofol).
5. Combining prophylactic phenylephrine with inhalation inductions.
4. Summary
At this time, prewarming is the most studied and likely the most effective 
method of reducing redistribution hypothermia, and improved outcomes have been 
documented. Unfortunately, it is not universally used. Given the priority of operat-
ing room expediency, either inhalation inductions or prophylactic administration of 
bolus phenylephrine are practical and can be used in virtually every anesthetizing 
location. Even though these techniques have been demonstrated to reduce redistri-
bution hypothermia, and post-induction temperatures are similar to what one sees 
after prewarming and a propofol induction, we can only anticipate but not yet infer 
the same improved outcomes will accrue. Although a strong correlation of adverse 
outcomes and hypothermia has been documented in numerous studies, an outcome 
study is needed. Inhalation inductions or prophylactic administration of phenyleph-
rine reduces redistribution hypothermia by reducing vasoconstriction; they do not 
add heat content. Prewarming reduces redistribution hypothermia by warming the 
periphery and adds heat content to the patient. Because the periphery needs to get 
warmed before forced-air warming increases the core temperature, it is likely that 
prewarmed patients will rewarm more rapidly, which is likely beneficial.
It is important to keep the operating room warm until the patient is prepped and 
draped. The temperature of a modern operating room can be decreased rapidly for 
the comfort of the operating room personnel. Putting a warm blanket on a patient 
as he/she enters a cold operating room does little to rewarm a patient. The skin 
temperature receptors have a disproportionate influence on the hypothalamus. The 
warm blanket may make the patient feel warmer, but the patient may still have lost 
significant heat content to the cool environment.
Besides from thermal benefits, financial benefits may accrue from reducing 
redistribution hypothermia. In the United States, the new Medicare Access and 
CHIP Reauthorization Act of 2015 (MACRA) temperature target (35.5°C) may now 
be easier to achieve [56]. Avoidance of unpleasant side effects (e.g., shivering) may 
result in less patient dissatisfaction. Reducing hypothermia-associated complica-
tions will reduce costs.
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